Early report on modular BioVAT patches in advanced stage C or D disease ...

Cardiac power output (CPO) represents the hydraulic energy generated by the heart and is calculated as the product of cardiac output and mean arterial pressure. As an integrative measure of ...

Heart failure is increasingly recognised as a disorder of cardiac energy metabolism as much as of pump function. Under normal conditions the myocardium flexibly switches between fatty acids, glucose ...

Experts warn that while heart transplants and mechanical support systems are saving lives, lack of awareness and delayed access to specialist care continue to cost many patients precious time.

The SGLT2 inhibitor medicines have changed how heart failure is managed. Originally, sodium-glucose cotransporter 2 (SGLT2) inhibitors were used to lower blood sugar levels in people who have type 2 ...

Cardiomyopathy weakens, enlarges, or stiffens the heart muscle. Heart failure is when the heart is unable to pump enough blood around the body, resulting in symptoms. Cardiomyopathy is one of the ...

Researchers have identified a key protein that may help failing hearts regain function, offering new insight into why some ...

Diastolic heart failure means there’s a problem with your heart’s ability to fill with blood. It’s a type of congestive heart failure where your heart cannot work efficiently, leading to fluid ...

Decompensated heart failure (DHF) means that symptoms from heart failure are severe enough to require immediate medical attention. Dyspnea or shortness of breath is the most common symptom of DHF.

Heart failure is when the heart does not pump enough blood around the body. Biventricular heart failure is when chambers on both sides of the heart, known as ventricles, are affected. Doctors classify ...

Research for other indications is ongoing. In the first trial of microRNA inhibition to treat heart failure, a novel agent did not reduce left ventricular end-systolic volume index at 6 months ...